Ampreloxetine Funding (Tables)

12 Months Ended

Dec. 31, 2023

Ampreloxetine Funding.

Schedule of future royalty payment contingencies

(In thousands)
Balance at December 31, 2022	$	25,438
Non-cash interest expense accretion		2,350
Balance at December 31, 2023	$	27,788